reviewTop 1% cited
Givosiran: First Approval
Drugs · 2020 · Vol. 80(3) · pp. 335–339
Lesley J. Scott✉(Springer Nature (New Zealand))
Porphyrin Metabolism and DisordersHeme Oxygenase-1 and Carbon MonoxideFolate and B Vitamins ResearchMedicinePharmacologyDownregulation and upregulationPorphobilinogenInternal medicinePorphyriaChemistryBiochemistry
MeSH terms
AcetylgalactosaminePorphobilinogen Synthase5-Aminolevulinate SynthetaseEnzyme InhibitorsHumansPyrrolidinesRNA, MessengerPorphyrias, HepaticDrug Approval
Citations
401
FWCI
21.11
field-weighted impact
References
10
Percentile
100%
vs. same field & year
Citations per year
Cited by
Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development
Journal of Clinical Medicine · 2020 · 516 citations
RNA-based therapeutics: an overview and prospectus
Cell Death and Disease · 2022 · 566 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
